Dr Lal PathLabs gets Sebi nod for IPO

Image
Press Trust of India New Delhi
Last Updated : Nov 09 2015 | 10:31 PM IST
Leading diagnostic chain Dr Lal PathLabs has received market regulator Sebi's approval to raise funds through an initial public offering (IPO). The company filed its Draft Red Herring Prospectus (DRHP) with Sebi on September 14 for the IPO, wherein the promoters and other existing shareholders will collectively sell 11.6 million shares of the company amounting to 14.1 per cent stake.

The Securities and Exchange Board of India (Sebi) has cleared the proposed initial share sale and gave its final observations on the IPO on November 3. The total amount of funds to be raised through the public offer would depend on the offer price to be decided later. Those participating in the share sale include main promoter Arvind Lal, as also other investors such as Wagner Ltd, Westbridge Crossover Fund and Sanjeevini Investment Holdings.

As per the DRHP filed with Sebi, the IPO would be made through an offer for sale and the proceeds would be remitted to the respective promoters and other investors and therefore the company will not receive any proceeds from the offer.

Kotak Mahindra Capital and Citigroup Global Markets India are the book running lead managers for the IPO.

The company said it is well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry.

Its total revenue rose to Rs 640 crore in the fiscal ended March 31, 2015, from Rs 544 crore in the previous year, while profit after tax rose to nearly Rs 88 crore from Rs 74 crore during the same period.

Since the beginning of 2015, as many as 39 companies filed draft documents with Sebi to float IPOs. In the same period, the market watchdog gave approval to 30 firms to launch their initial share sale plans, some of which were pending from previous year.

So far this year, 18 companies have launched their IPOs and have collectively raised about nearly Rs 11,000 crore, making it the best period in four years in terms of fund raising through initial share-sale programmes.

In comparison, six IPOs had hit the market in the entire 2014 and together garnered just Rs 1,261 crore, while three firms had launched their public issues in 2013 to mobilise Rs 1,284 crore.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 09 2015 | 10:29 PM IST

Next Story